"The consensus was that no one knew what was going on. No one knew what to do. Everything took a long time to occur, and that's the unfortunate thing." ...

H.C. Wainwright analyst Joseph Pantginis maintained a Buy rating on Tenaya Therapeutics Inc (NASDAQ:TNYA), with a price target of $18.00. This aligns with the strong overall analyst consensus, as ...

Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of ...

South San Francisco, CA, January 30, 2025 – The California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated to regenerative medicine, has awarded nearly ...

My daughter Clarissa was full of energy and kindness, she had a magnetic presence that made everyone feel special. At 20, she ...

View all available purchase options and get full access to this article. Department of Cardiology, Cardiovascular Research Institute Maastricht, Maastricht University ...

In this study, we sought to (1) assess for cutaneous features including PPK and tightly curled/kinky hair among patients with autosomal dominant ACM caused by DSP variants, (2) relate cutaneous ...